83N-20632-91837
4 vaccinations
2 coded responses
31 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 762 / TX
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
-
2021-04-09
Dose 2 — Pfizer-BioNTech
-
2021-04-09
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · HeadacheAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fatigue or tirednessAdult check-in
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · None · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-18
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
-
2021-10-08
Survey response — 6 months, dose 2MedDRA: Adverse reaction, COVID-19 pneumonia, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had covid 19 with covid pneumonia with no hospitalization. treated with monoclonal antibodies and an inhaler. symptoms started august 27th. Tested positive on august 29th. received monoclonal antibodies on september 3rd.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-17
Dose 3 — Moderna
-
2022-09-20
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-28
- 2022-10-06
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-12-20
-
2023-03-23
Survey response — 6 months, dose 4MedDRA: Thyroid cancer — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-03-23
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2022-01-17 | Moderna | No |
| 4 | 2022-09-20 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 6 months, dose 2
Symptoms: Had covid 19 with covid pneumonia with no hospitalization. treated with monoclonal antibodies and an inhaler. symptoms started august 27th. Tested positive on august 29th. received monoclonal antibodies on september 3rd.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | COVID-19 pneumonia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Thyroid cancer | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release